Literature DB >> 31229516

Healthcare Costs of Post-Prostate Biopsy Sepsis.

Michael D Gross1, Mark N Alshak2, Jonathan E Shoag1, Aaron A Laviana3, Michael A Gorin4, Art Sedrakyan5, Jim C Hu6.   

Abstract

Sepsis following transrectal prostate biopsy occurs in 2%-5% of cases and the risk is increasing. We performed a comprehensive literature search for the cost of post-prostate biopsy sepsis to define the potential cost savings of reducing infectious complications. Reporting of cost is varied and presents a challenge to interpretation. Length of hospitalization ranged from 1.1 to 14 days and the percent admitted to an ICU ranged from 1.1% to 25%. The estimated cost of sepsis post-prostate biopsy, adjusted for inflation, ranged from $8,672 to $19,100. Healthcare costs of treating post-biopsy infection are substantial. Our findings should guide payers and policymakers, especially in value-based care models.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31229516     DOI: 10.1016/j.urology.2019.06.011

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  11 in total

1.  Enhanced antibiotic prophylaxis and infection-related complications following prostate biopsy.

Authors:  Rebecca S Steinberg; Lauren Kipling; K C Biebighauser Bens; Dattatraya Patil; Mark Henry; Akanksha Mehta; Christopher Filson
Journal:  World J Urol       Date:  2021-03-26       Impact factor: 3.661

Review 2.  Hundred years of transperineal prostate biopsy.

Authors:  Benjamin Schmeusser; Brandon Levin; Daniel Lama; Abhinav Sidana
Journal:  Ther Adv Urol       Date:  2022-05-21

Review 3.  Developments in optimizing transperineal prostate biopsy.

Authors:  Emily Cheng; Meenakshi Davuluri; Patrick J Lewicki; Jim C Hu; Spyridon P Basourakos
Journal:  Curr Opin Urol       Date:  2022-01-01       Impact factor: 2.808

Review 4.  Pooled outcomes of performing freehand transperineal prostate biopsy with the PrecisionPoint Transperineal Access System.

Authors:  Michael Tzeng; Spyridon P Basourakos; Hiten D Patel; Matthew J Allaway; Jim C Hu; Michael A Gorin
Journal:  BJUI Compass       Date:  2022-06-28

Review 5.  Rationale and protocol for randomized study of transrectal and transperineal prostate biopsy efficacy and complications (ProBE-PC study).

Authors:  Badar M Mian; Ronald P Kaufman; Hugh A G Fisher
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-03-25       Impact factor: 5.554

Review 6.  "TREXIT 2020": why the time to abandon transrectal prostate biopsy starts now.

Authors:  Jeremy Grummet; Michael A Gorin; Rick Popert; Tim O'Brien; Alastair D Lamb; Boris Hadaschik; Jan Philipp Radtke; Florian Wagenlehner; Eduard Baco; Caroline M Moore; Mark Emberton; Arvin K George; John W Davis; Richard J Szabo; Roger Buckley; Andrew Loblaw; Matthew Allaway; Christof Kastner; Erik Briers; Peter L Royce; Mark Frydenberg; Declan G Murphy; Henry H Woo
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-01-13       Impact factor: 5.554

7.  Multicentre clinical evaluation of the safety and performance of a simple transperineal access system for prostate biopsies for suspected prostate cancer: The CAMbridge PROstate Biopsy DevicE (CamPROBE) study.

Authors:  Vincent J Gnanapragasam; Kelly Leonard; Michal Sut; Cristian Ilie; Jonathan Ord; Jacques Roux; Maria Consuelo Hart Prieto; Anne Warren; Priya Tamer
Journal:  J Clin Urol       Date:  2020-06-12

Review 8.  Transrectal Ultrasound in Prostate Cancer: Current Utilization, Integration with mpMRI, HIFU and Other Emerging Applications.

Authors:  John Panzone; Timothy Byler; Gennady Bratslavsky; Hanan Goldberg
Journal:  Cancer Manag Res       Date:  2022-03-22       Impact factor: 3.989

9.  Magnetic resonance imaging /ultrasonography fusion transperineal prostate biopsy for prostate cancer: Initial experience at a Middle Eastern tertiary medical centre.

Authors:  Adnan El-Achkar; Mouhammad Al-Mousawy; Nassib Abou Heidar; Hisham Moukaddem; Hero Hussein; Nadim Mouallem; Albert El-Hajj; Muhammad Bulbul
Journal:  Arab J Urol       Date:  2021-07-14

10.  Topical antiseptic at time of transrectal ultrasound prostate biopsy is associated with fewer severe clinical infections and improves antibiotic stewardship.

Authors:  Shayann Ramedani; Joseph Y Clark; John J Knoedler; Susan MacDonald; Matthew G Kaag; Suzanne B Merrill; Jay D Raman
Journal:  Prostate Int       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.